0001354488-13-005534.txt : 20131003 0001354488-13-005534.hdr.sgml : 20131003 20131002180343 ACCESSION NUMBER: 0001354488-13-005534 CONFORMED SUBMISSION TYPE: SC 13D/A PUBLIC DOCUMENT COUNT: 3 FILED AS OF DATE: 20131003 DATE AS OF CHANGE: 20131002 GROUP MEMBERS: ATLAS REAL ESTATE FUNDS INC. GROUP MEMBERS: BRETT TORINO GROUP MEMBERS: KANAVOS DYNASTY TRUST 2011 GROUP MEMBERS: PAUL C. KANAVOS GROUP MEMBERS: TS 2013 LLC GROUP MEMBERS: TTERB LIVING TRUST SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Circle Entertainment, Inc. CENTRAL INDEX KEY: 0001410402 STANDARD INDUSTRIAL CLASSIFICATION: REAL ESTATE [6500] IRS NUMBER: 364612924 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-83515 FILM NUMBER: 131131561 BUSINESS ADDRESS: STREET 1: 650 MADISON AVENUE CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: 212-838-3100 MAIL ADDRESS: STREET 1: 650 MADISON AVENUE CITY: NEW YORK STATE: NY ZIP: 10022 FORMER COMPANY: FORMER CONFORMED NAME: FX Real Estate & Entertainment Inc. DATE OF NAME CHANGE: 20070822 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: SILLERMAN ROBERT F X CENTRAL INDEX KEY: 0000940128 FILING VALUES: FORM TYPE: SC 13D/A MAIL ADDRESS: STREET 1: 150 EAST 58TH STREET CITY: NEW YORK STATE: NY ZIP: 10155 SC 13D/A 1 cexe_sc13d.htm SCHEDULE 13D/A cexe_sc13d.htm


SECURITIES AND EXCHANGE COMMISSION
 
Washington, D.C. 20549
 
SCHEDULE 13D
 
Under the Securities Exchange Act of 1934
(Amendment No. 22)*
 
Circle Entertainment Inc.
(Name of Issuer)
 
Common Stock, par value $0.01 per share
(Title of Class of Securities)
 
17256R-105
(CUSIP Number)
 
Mitchell J. Nelson
Atlas Real Estate Funds, Inc.
70 East 55th Street
New York, New York 10022
Telephone: (212) 796-8199
(Name, address and telephone number of person
authorized to receive notices and communications)
 
September 30, 2013
(Date of event which requires filing of this statement)
 
If the filing person has previously filed a statement on Schedule 13G to report the acquisition which is the subject of this Schedule 13D, and is filing this schedule because of Rule 13d-1(e), Rule 13d-1(f) or Rule 13d-1(g), check the following box .o
 
NOTE:  Schedules filed in paper format shall include a signed original and five copies of the Schedule, including all exhibits.  See Rule 13d-7(b) for other parties to whom copies are to be sent.
 
————————————————
*The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.
 
The information required on the remainder of this cover page shall not be deemed to be “filed” for purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes)
 


 
 
 
 
CUSIP No. 17256R-105 SCHEDULE 13D Page 2 of 16 Pages
 
1
NAME OF REPORTING PERSONS
 
Robert F.X. Sillerman
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
 (a) o
 (b) þ
3
SEC USE ONLY
 
 
4
SOURCE OF FUNDS
 
 
5
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) or 2(e) o
 
 
6
CITIZENSHIP OR PLACE OF ORGANIZATION
 
United States
 
NUMBER OF
7
SOLE VOTING POWER
9,350,263
 
SHARES
BENEFICIALLY
8
SHARED VOTING POWER
23,910,664
 
OWNED BY
EACH
9
SOLE DISPOSITIVE POWER
9,350,263
 
REPORTING
PERSON WITH
10
SHARED DISPOSITIVE POWER
23,910,664
 
11
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
32,760,927
12
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES  o
 
 
13
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
 
41.4%1
14
TYPE OF REPORTING PERSON
 
IN
 

1 See Item 5(a) herein.
 
 
2

 
 
CUSIP No. 17256R-105 SCHEDULE 13D Page 3 of 16 Pages
 
1
NAME OF REPORTING PERSONS
 
Paul C. Kanavos
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
 (a) o
 (b) þ
3
SEC USE ONLY
 
 
4
SOURCE OF FUNDS
 
 
5
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) or 2(e) o
 
 
6
CITIZENSHIP OR PLACE OF ORGANIZATION
 
United States
 
NUMBER OF
7
SOLE VOTING POWER
1,034,254
 
SHARES
BENEFICIALLY
8
SHARED VOTING POWER
38,901,700
 
OWNED BY
EACH
9
SOLE DISPOSITIVE POWER
1,034,254
 
REPORTING
PERSON WITH
10
SHARED DISPOSITIVE POWER
38,901,700
 
11
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
39,935,954
12
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES  o
 
 
13
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
 
49.0%2
14
TYPE OF REPORTING PERSON
 
IN
 

2 See Item 5(a) herein.
 
 
3

 
 
CUSIP No. 17256R-105 SCHEDULE 13D Page 4 of 16 Pages
 
1
NAME OF REPORTING PERSONS
 
Kanavos Dynasty Trust 2011
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
 (a) o
 (b) þ
3
SEC USE ONLY
 
 
4
SOURCE OF FUNDS
 
 
5
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) or 2(e) o
 
 
6
CITIZENSHIP OR PLACE OF ORGANIZATION
 
Delaware
 
NUMBER OF
7
SOLE VOTING POWER
0
 
SHARES
BENEFICIALLY
8
SHARED VOTING POWER
11,056,870
 
OWNED BY
EACH
9
SOLE DISPOSITIVE POWER
0
 
REPORTING
PERSON WITH
10
SHARED DISPOSITIVE POWER
11,056,870
 
11
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
11,056,870
12
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES  o
 
 
13
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
 
15.7%3
14
TYPE OF REPORTING PERSON
 
OO
 

3 See Item 5(a) herein.
 
 
4

 
 
CUSIP No. 17256R-105 SCHEDULE 13D Page 5 of 16 Pages
 
1
NAME OF REPORTING PERSONS
 
Brett Torino
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
 (a) o
 (b) þ
3
SEC USE ONLY
 
 
4
SOURCE OF FUNDS
 
 
5
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) or 2(e) o
 
 
6
CITIZENSHIP OR PLACE OF ORGANIZATION
 
United States
 
NUMBER OF
7
SOLE VOTING POWER
176,238
 
SHARES
BENEFICIALLY
8
SHARED VOTING POWER
38,235,221
 
OWNED BY
EACH
9
SOLE DISPOSITIVE POWER
176,238
 
REPORTING
PERSON WITH
10
SHARED DISPOSITIVE POWER
38,235,221
 
11
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
38,411,459
12
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES  o
 
 
13
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
 
46.4%4
14
TYPE OF REPORTING PERSON
 
IN
 

4 See Item 5(a) herein.
 
 
5

 
 
CUSIP No. 17256R-105 SCHEDULE 13D Page 6 of 16 Pages
 
1
NAME OF REPORTING PERSONS
 
TTERB Living Trust
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
 (a) o
 (b) þ
3
SEC USE ONLY
 
 
4
SOURCE OF FUNDS
 
 
5
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) or 2(e) o
 
 
6
CITIZENSHIP OR PLACE OF ORGANIZATION
 
Nevada
 
NUMBER OF
7
SOLE VOTING POWER
0
 
SHARES
BENEFICIALLY
8
SHARED VOTING POWER
28,370,677
 
OWNED BY
EACH
9
SOLE DISPOSITIVE POWER
0
 
REPORTING
PERSON WITH
10
SHARED DISPOSITIVE POWER
28,370,677
 
11
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
28,370,677
12
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES  o
 
 
13
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
 
35.2%5
14
TYPE OF REPORTING PERSON
 
OO
 

5 See Item 5(a) herein.
 
 
6

 
 
CUSIP No. 17256R-105 SCHEDULE 13D Page 7 of 16 Pages
 
1
NAME OF REPORTING PERSONS
 
TS 2013 LLC
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
 (a) o
 (b) þ
3
SEC USE ONLY
 
 
4
SOURCE OF FUNDS
 
WC
5
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) or 2(e) o
 
 
6
CITIZENSHIP OR PLACE OF ORGANIZATION
 
Nevada
 
NUMBER OF
7
SOLE VOTING POWER
0
 
SHARES
BENEFICIALLY
8
SHARED VOTING POWER
9,864,544
 
OWNED BY
EACH
9
SOLE DISPOSITIVE POWER
0
 
REPORTING
PERSON WITH
10
SHARED DISPOSITIVE POWER
9,864,544
 
11
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
9,864,544
12
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES  o
 
 
13
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
 
14.7%6
14
TYPE OF REPORTING PERSON
 
OO
 

6 See Item 5(a) herein.
 
 
7

 
 
CUSIP No. 17256R-105 SCHEDULE 13D Page 8 of 16 Pages
 
1
NAME OF REPORTING PERSONS
 
Atlas Real Estate Funds, Inc.
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
 (a) o
 (b) þ
3
SEC USE ONLY
 
 
4
SOURCE OF FUNDS
 
 
5
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) or 2(e) o
 
 
6
CITIZENSHIP OR PLACE OF ORGANIZATION
 
Delaware
 
NUMBER OF
7
SOLE VOTING POWER
0
 
SHARES
BENEFICIALLY
8
SHARED VOTING POWER
5,501,611
 
OWNED BY
EACH
9
SOLE DISPOSITIVE POWER
0
 
REPORTING
PERSON WITH
10
SHARED DISPOSITIVE POWER
5,501,611
 
11
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
5,501,611
12
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES  o
 
 
13
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
 
8.5%7
14
TYPE OF REPORTING PERSON
 
CO
 

7 See Item 5(a) herein.
 
 
8

 
 
CUSIP No. SCHEDULE 13D Page 9 of 16 Pages
 
This Amendment No. 22 amends the Statement of Beneficial Ownership on Schedule 13D originally filed with the Securities and Exchange Commission (“SEC”) on January 10, 2008 by Robert F.X. Sillerman (“Sillerman”), Sillerman Commercial Holdings Partnership, L.P., a Delaware limited partnership, and Sillerman Capital Holdings, L.P., a Delaware limited partnership (“Holdings”), with respect to the common stock, par value $0.01 per share (the “Common Stock”), of Circle Entertainment Inc. (formerly known as FX Real Estate and Entertainment Inc.), a Delaware corporation (the “Issuer”), as amended by Amendment No. 1 filed with the SEC on March 13, 2008 by Sillerman and Holdings, as amended by Amendment No. 2 filed with the SEC on May 15, 2008 by Sillerman and Holdings, as amended by Amendment No. 3 filed with the SEC on December 30, 2008 by Sillerman, Holdings, Paul C. Kanavos (“Kanavos”), Brett Torino (“Torino”), ONIROT Living Trust dated 6/20/2000 (“ONIROT”), TTERB Living Trust (“TTERB”) and Atlas Real Estate Funds, Inc. (“Atlas”), as amended by Amendment No. 4 filed with the SEC on September 10, 2009 by Sillerman, Holdings, Kanavos, Torino, ONIROT, TTERB and Atlas, as amended by Amendment No. 5 filed with the SEC on November 9, 2009 by Sillerman, Holdings, Kanavos, Torino, ONIROT, TTERB and Atlas, as amended by Amendment No. 6 filed with the SEC on November 18, 2009 by Sillerman, Holdings, Kanavos, Torino, ONIROT, TTERB and Atlas, as amended by Amendment No. 7 filed with the SEC on December 24, 2009 by Sillerman, Holdings, Kanavos, Torino, ONIROT, TTERB and Atlas, as amended by Amendment No. 8 filed with the SEC on December 29, 2009 by Sillerman, Holdings, Kanavos, Torino, ONIROT, TTERB and Atlas, as amended by Amendment No. 9 filed with the SEC on January 29, 2010 by Sillerman, Holdings, Kanavos, Torino, ONIROT, TTERB and Atlas, as amended by Amendment No. 10 filed with the SEC on February 10, 2010 by Sillerman, Holdings, Kanavos, Torino, ONIROT, TTERB and Atlas, as amended by Amendment No. 11 filed with the SEC on February 19, 2010 by Sillerman, Holdings, Kanavos, Torino, ONIROT, TTERB and Atlas, as amended by Amendment No. 12 filed with the SEC on March 18, 2010 by Sillerman, Holdings, Kanavos, Torino, ONIROT, TTERB and Atlas, as amended by Amendment No. 13 filed with the SEC on April 12, 2010 by Sillerman, Holdings, Kanavos, Torino, ONIROT, TTERB and Atlas, as amended by Amendment No. 14 filed with the SEC on April 23, 2010 by Sillerman, Holdings, Kanavos, Torino, ONIROT, TTERB and Atlas, as amended by Amendment No. 15 filed with the SEC on May 6, 2010 by Sillerman, Holdings, Kanavos, Torino, ONIROT, TTERB and Atlas, as amended by Amendment No. 16 filed with the SEC on June 8, 2010 by Sillerman, Holdings, Kanavos, Torino, ONIROT, TTERB and Atlas, as amended by Amendment No. 17 filed with the SEC on July 12, 2010 by Sillerman, Holdings, Kanavos, Torino, ONIROT, TTERB and Atlas, as amended by Amendment No. 18 filed with the SEC on August 19, 2010 by Sillerman, Holdings, Kanavos, Torino, ONIROT, TTERB and Atlas, as amended by Amendment No. 19 filed with the SEC on October 1, 2010 by Sillerman, Holdings, Kanavos, Torino, ONIROT, TTERB and Atlas, as amended by Amendment No. 20 filed with the SEC on December 3, 2010 by Sillerman, Holdings, Kanavos, Torino, ONIROT, TTERB and Atlas and as amended by Amendment No. 21 filed with the SEC on September 22, 2011 by Sillerman, Holdings, Kanavos, Torino, ONIROT, TTERB, Atlas and the Kanavos Dynasty Trust 2011 (“KDT”) (as amended, the “Statement”).  This Amendment No. 22 is being filed by Sillerman, Kanavos, KDT, Torino, TTERB, Atlas and TS 2013 LLC (“TS”). From and after the date hereof, all references in the Statement to the Statement or terms of similar import shall be deemed to refer to the Statement as amended by this Amendment No. 22.  All capitalized terms used but not defined herein have the respective meanings ascribed to such terms in the Statement.
 
Sillerman, Holdings, Kanavos, KDT, Torino, TTERB, TS and Atlas (collectively, the “Reporting Persons”) have entered into a Fourth Amended and Restated Joint Filing Agreement, dated October 2, 2013, a copy of which has been filed as Exhibit 26 to the Statement, and which is incorporated herein by reference. Neither the fact of this filing nor anything contained herein shall be deemed an admission by the Reporting Persons that they constitute a "group" as such term is used in Section 13(d)(1)(k) of the rules and regulations under the Securities Exchange Act of 1934, as amended.
 
Items 2, 3, 4, 5, 6 and 7 of the Statement are hereby amended to the extent hereinafter expressly set forth.
 
Item 2.
Identity and Background.
 
Item 2 of the Statement is hereby amended to add the following information:
 
(a), (b), (c), (d), (e) and (f). TS is a limited liability company of which ONIROT is the sole member. Torino is the sole trustee of ONIROT. As the sole trustee of ONIROT, which is the sole member of TS, Torino exercises voting and investment power over the shares of Common Stock held by TS. TS was organized in the State of Nevada and its business address is 4455 Wagon Trail Avenue, Las Vegas, Nevada 89118. To the knowledge of the Reporting Persons, TS has neither, during the last five years, been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors) or been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws.

Item 3.
Source or Amount of Funds or Other Consideration.
 
Item 3 of the Statement is hereby amended to add the following information:
 
On September 30, 2013, TS and The Huff Alternative Fund, L.P. and The Huff Alternative Parallel Fund, L.P. (collectively, the “Huff Funds”) entered into a securities purchase and sale agreement (the “Purchase Agreement”) pursuant to which TS purchased from the Huff Funds in a private transaction (i) an aggregate of 7,781,209 shares of Common Stock at a purchase price of $0.025 per share, (ii) an aggregate of 1,041,667 common stock purchase warrants to purchase up to 1,041,667 shares of Common Stock at an exercise price of $0.07 per share for a purchase price of $0.00263 per warrant, (iii) an aggregate of 1,041,667 common stock purchase warrants to purchase up to 1,041,667 shares of Common Stock at an exercise price of $0.08 per share for a purchase price of $0.00263 per warrant and (iv) one share of Issuer Non-Voting Designated Preferred Stock for $0.00263 (which share of Non-Voting Designated Preferred Stock the Issuer immediately converted into a single share of Common Stock by reason of exercising its right of conversion thereof as a result of TS’s purchase of the shares of Common Stock in above clause (i)).  TS purchased these securities with cash on hand.

 
9

 
CUSIP No. 17256R-105 SCHEDULE 13D Page 10 of 16 Pages
 
Item 4.
Purpose of the Transaction.

                Item 4 of the Statement is hereby amended to add the following information:

TS  purchased the securities in the private transaction described in Item 3 above for investment purposes.  No Reporting Person has any present plan or proposal which relates to or would result in any of the actions set forth in subparagraphs (a) through (j) of Item 4 of Schedule 13D.  However, each of the Reporting Persons intends to continue to review its investment in the Issuer, and will explore alternative ways to maximize its return on such investment.  In this connection, some of the Reporting Persons intend to engage in discussions with the Board of Directors of the Issuer concerning the future plans of the Issuer in light of the fact that the Issuer does not currently generate any revenue from its location-based entertainment line of business, the Issuer has significant capital and financing requirements to develop and commercialize its location-based entertainment line of business with virtually no sources of funding, certain of the Reporting Persons are the Issuer’s largest creditors and the Issuer has expressed doubt about its ability to continue as a going concern.  Accordingly, one or more of the Reporting Persons may in the future take actions with respect to their investment in the Issuer that may result in formulating a plan or proposal which relates to or would result in one or more of the actions set forth in subparagraphs (a) through (j) of Item 4 of Schedule 13D.

Item 5.
Interest in Securities of the Issuer.

Item 5 of the Statement is hereby amended and restated in its entirety as to paragraphs (a) through (c) thereof:
 
(a) As of the date of this Statement:
 
Sillerman beneficially owns (i) directly 14,103,806 shares of Common Stock (consisting of: (A) 8,850,263 shares of Common Stock owned by Sillerman; (B) 250,000 shares of Common Stock issuable upon the exercise of stock options held by Sillerman that are presently exercisable at $5.00 per share; (C) 856,531 shares of Common Stock issuable upon the conversion of the Issuer’s Series A Convertible Preferred Shares held by Sillerman and his spouse, as joint tenants, that are convertible at $0.2335 per share8; (D) 2,055,498 shares of Common Stock issuable upon the exercise of warrants held by Sillerman and his spouse that are presently exercisable at $0.2919 per share; (E) 369,913 shares of Common Stock issuable upon the conversion of the Issuer’s Series A Convertible Preferred Shares held by Sillerman and his spouse, as joint tenants, that are convertible at $0.2433 per share9; (F) 888,011 shares of Common Stock issuable upon the exercise of warrants held by Sillerman and his spouse that are presently exercisable at $0.3041 per share; (G) 171,606  shares of Common Stock issuable upon the conversion of the Issuer’s Series A Convertible Preferred Shares held by Sillerman and his spouse, as joint tenants, that are convertible at $0.1923 per share10;
 

8 The Series A Convertible Preferred Shares are convertible, at the option of the holder, into shares of Common Stock at the above conversion price if at any time the closing price of the shares of Common Stock is at least the conversion price for ten (10) consecutive trading days. Each time, for a period of 60-days thereafter, the Series A Convertible Preferred Shares are convertible into the number of shares of Common Stock equal to the then current stated value (initially $1,000, subject to increase periodically to include any accrued and unpaid  dividends) divided by the conversion price.  Upon the earlier of: (x) consummation of the Issuer’s sale (or series of related sales) of its capital stock (or securities convertible into its capital stock) from which the Issuer generates net proceeds of at least $25 million or (y) March 11, 2015 the Series A Convertible Preferred Shares shall automatically convert into the number of shares of Common Stock equal to the then current stated value divided by the conversion price.  If at any time the closing price of the shares of Common Stock is at least $1.94 for fifteen (15) consecutive trading days, the Issuer may redeem the outstanding Series A Convertible Preferred Shares at the then current stated value. The Series A Preferred Shares are redeemable each time in whole or in part for a period of 120-days thereafter. 
 
9 The Series A Convertible Preferred Shares are convertible, at the option of the holder, into shares of Common Stock at the above conversion price if at any time the closing price of the shares of Common Stock is at least the conversion price for ten (10) consecutive trading days. Each time, for a period of 60-days thereafter, the Series A Convertible Preferred Shares are convertible into the number of shares of Common Stock equal to the then current stated value (initially $1,000, subject to increase periodically to include any accrued and unpaid  dividends) divided by the conversion price.  Upon the earlier of: (x) consummation of the Issuer’s sale (or series of related sales) of its capital stock (or securities convertible into its capital stock) from which the Issuer generates net proceeds of at least $25 million or (y) April 5, 2015 the Series A Convertible Preferred Shares shall automatically convert into the number of shares of Common Stock equal to the then current stated value divided by the conversion price.  If at any time the closing price of the shares of Common Stock is at least $2.02 for fifteen (15) consecutive trading days, the Issuer may redeem the outstanding Series A Convertible Preferred Shares at the then current stated value. The Series A Preferred Shares are redeemable each time in whole or in part for a period of 120-days thereafter.
 
10The Series A Convertible Preferred Shares are convertible, at the option of the holder, into shares of Common Stock at the above conversion price if at any time the closing price of the shares of Common Stock is at least the conversion price for ten (10) consecutive trading days. Each time, for a period of 60-days thereafter, the Series A Convertible Preferred Shares are convertible into the number of shares of Common Stock equal to the then current stated value (initially $1,000, subject to increase periodically to include any accrued and unpaid  dividends) divided by the conversion price.  Upon the earlier of: (x) consummation of the Issuer’s sale (or series of related sales) of its capital stock (or securities convertible into its capital stock) from which the Issuer generates net proceeds of at least $25 million or (y) June 4, 2015 the Series A Convertible Preferred Shares shall automatically convert into the number of shares of Common Stock equal to the then current stated value divided by the conversion price.  If at any time the closing price of the shares of Common Stock is at least $1.60 for fifteen (15) consecutive trading days, the Issuer may redeem the outstanding Series A Convertible Preferred Shares at the then current stated value. The Series A Preferred Shares are redeemable each time in whole or in part for a period of 120-days thereafter.  
 
10

 
CUSIP No. 17256R-105 SCHEDULE 13D Page 11 of 16 Pages
 
 (H) 411,984 shares of Common Stock issuable upon the exercise of warrants held by Sillerman and his spouse that are presently exercisable at $0.2403 per share; and (I) 250,000 shares of Common Stock issuable upon the exercise of stock options held by Sillerman that are presently exercisable at $6.00 per share); and (ii) indirectly 18,657,121 shares of Common Stock (consisting of:  (A) 4,423,264 shares of Common Stock owned of record by Laura Baudo Sillerman, Sillerman’s spouse; (B) 390,626 shares of Common Stock issuable upon the exercise of warrants held by Sillerman’s spouse that are presently exercisable at $0.08 per share; (C) 2,777,778 shares of Common Stock issuable upon the exercise of warrants held by Sillerman’s spouse, half of which are presently exercisable at $0.10 per share and the other half of which are presently exercisable at $0.11 per shares; (D) 151,099 shares of Common Stock issuable upon the conversion of the Issuer’s Series A Convertible Preferred Shares held by Sillerman’s spouse that are convertible at $0.2184 per share11; (E) 362,637 shares of Common Stock issuable upon the exercise of warrants held by Sillerman’s spouse that are presently exercisable at $0.273 per share; (F) 257,732 shares of Common Stock issuable upon the conversion of the Issuer’s Series A Convertible Preferred Shares held by Sillerman’s spouse that are convertible at $0.2328 per share12; (G) 618,557 shares of Common Stock issuable upon the exercise of warrants held by Sillerman’s spouse that are presently exercisable at $0.291 per share; (H) 238,435 shares of Common Stock issuable upon the conversion of the Issuer’s Series A Convertible Preferred Shares held by Sillerman’s spouse that are convertible at $0.2097 per share13; (I) 572,410 shares of Common Stock issuable upon the exercise of warrants held by Sillerman’s spouse that are presently exercisable at $0.2621 per share; (J) 210,630 shares of Common Stock issuable upon the conversion of the Issuer’s Series A Convertible Preferred Shares held by Sillerman’s spouse that are convertible at $0.1614 per share14;
 

11 The Series A Convertible Preferred Shares are convertible, at the option of the holder, into shares of Common Stock at the above conversion price if at any time the closing price of the shares of Common Stock is at least the conversion price for ten (10) consecutive trading days. Each time, for a period of 60-days thereafter, the Series A Convertible Preferred Shares are convertible into the number of shares of Common Stock equal to the then current stated value (initially $1,000, subject to increase periodically to include any accrued and unpaid  dividends) divided by the conversion price.  Upon the earlier of: (x) consummation of the Issuer’s sale (or series of related sales) of its capital stock (or securities convertible into its capital stock) from which the Issuer generates net proceeds of at least $25 million or (y) February 11, 2015 the Series A Convertible Preferred Shares shall automatically convert into the number of shares of Common Stock equal to the then current stated value divided by the conversion price.  If at any time the closing price of the shares of Common Stock is at least $1.82 for fifteen (15) consecutive trading days, the Issuer may redeem the outstanding Series A Convertible Preferred Shares at the then current stated value. The Series A Preferred Shares are redeemable each time in whole or in part for a period of 120-days thereafter.
 
12 The Series A Convertible Preferred Shares are convertible, at the option of the holder, into shares of Common Stock at the above conversion price if at any time the closing price of the shares of Common Stock is at least the conversion price for ten (10) consecutive trading days. Each time, for a period of 60-days thereafter, the Series A Convertible Preferred Shares are convertible into the number of shares of Common Stock equal to the then current stated value (initially $1,000, subject to increase periodically to include any accrued and unpaid  dividends) divided by the conversion price.  Upon the earlier of: (x) consummation of the Issuer’s sale (or series of related sales) of its capital stock (or securities convertible into its capital stock) from which the Issuer generates net proceeds of at least $25 million or (y) March 5, 2015 the Series A Convertible Preferred Shares shall automatically convert into the number of shares of Common Stock equal to the then current stated value divided by the conversion price.  If at any time the closing price of the shares of Common Stock is at least $1.94 for fifteen (15) consecutive trading days, the Issuer may redeem the outstanding Series A Convertible Preferred Shares at the then current stated value. The Series A Preferred Shares are redeemable each time in whole or in part for a period of 120-days thereafter.

13 The Series A Convertible Preferred Shares are convertible, at the option of the holder, into shares of Common Stock at the above conversion price if at any time the closing price of the shares of Common Stock is at least the conversion price for ten (10) consecutive trading days. Each time, for a period of 60-days thereafter, the Series A Convertible Preferred Shares are convertible into the number of shares of Common Stock equal to the then current stated value (initially $1,000, subject to increase periodically to include any accrued and unpaid  dividends) divided by the conversion price.  Upon the earlier of: (x) consummation of the Issuer’s sale (or series of related sales) of its capital stock (or securities convertible into its capital stock) from which the Issuer generates net proceeds of at least $25 million or (y) May 3, 2015 the Series A Convertible Preferred Shares shall automatically convert into the number of shares of Common Stock equal to the then current stated value divided by the conversion price.  If at any time the closing price of the shares of Common Stock is at least $1.74 for fifteen (15) consecutive trading days, the Issuer may redeem the outstanding Series A Convertible Preferred Shares at the then current stated value. The Series A Preferred Shares are redeemable each time in whole or in part for a period of 120-days thereafter.
 
14 The Series A Convertible Preferred Shares are convertible, at the option of the holder, into shares of Common Stock at the above conversion price if at any time the closing price of the shares of Common Stock is at least the conversion price for ten (10) consecutive trading days. Each time, for a period of 60-days thereafter, the Series A Convertible Preferred Shares are convertible into the number of shares of Common Stock equal to the then current stated value (initially $1,000, subject to increase periodically to include any accrued and unpaid  dividends) divided by the conversion price.  Upon the earlier of: (x) consummation of the Issuer’s sale (or series of related sales) of its capital stock (or securities convertible into its capital stock) from which the Issuer generates net proceeds of at least $25 million or (y) July 7, 2015 the Series A Convertible Preferred Shares shall automatically convert into the number of shares of Common Stock equal to the then current stated value divided by the conversion price.  If at any time the closing price of the shares of Common Stock is at least $1.34 for fifteen (15) consecutive trading days, the Issuer may redeem the outstanding Series A Convertible Preferred Shares at the then current stated value. The Series A Preferred Shares are redeemable each time in whole or in part for a period of 120-days thereafter.
 
 
 
11

 
CUSIP No. 17256R-105 SCHEDULE 13D Page 12 of 16 Pages
 
(K) 505,575 shares of Common Stock issuable upon the exercise of warrants held by Sillerman’s spouse that are presently exercisable at $0.2018 per share; (L) 260,552 shares of Common Stock issuable upon the conversion of the Issuer’s Series B Convertible Preferred Shares held by Sillerman’s spouse that are convertible at $0.1919 per share15; (M) 625,390 shares of Common Stock issuable upon the exercise of warrants held by Sillerman’s spouse that are presently exercisable at $0.2399 per share; (N) 560,600 shares of Common Stock issuable upon the conversion of the Issuer’s Series B Convertible Preferred Shares held by Sillerman’s spouse that are convertible at $0.2107 per share16; (O) 1,138,952 shares of Common Stock issuable upon the exercise of warrants held by Sillerman’s spouse that are presently exercisable at $0.2634 per share; (P) 18,023 shares of Common Stock issuable upon the conversion of Series B Convertible Preferred Shares held by Sillerman’s spouse that are convertible at $0.4622 per share17; (Q) 43,250 shares of Common Stock issuable upon the exercise of warrants held by Sillerman’s spouse that are presently exercisable at $0.5778 per share; and (R) 5,501,611 shares of Common Stock owned of record by Atlas), which shares of Common Stock represent in the aggregate approximately 41.4% of the 79,061,950 shares of Common Stock deemed outstanding for such purpose, calculated based upon the sum of (x) 65,076,161 shares of Common Stock outstanding as of the date of this Statement and (y) the 13,985,789 shares of Common Stock issuable upon exercise of the aforesaid stock options, Series A Convertible Preferred Shares, Series B Convertible Preferred Shares and warrants.
 

15 The Series B Convertible Preferred Shares are convertible, at the option of the holder, into shares of Common Stock at the above conversion price if at any time the closing price of the shares of Common Stock is at least the conversion price for ten (10) consecutive trading days. Each time, for a period of 60-days thereafter, the Series B Convertible Preferred Shares are convertible into the number of shares of Common Stock equal to the then current stated value (initially $1,000, subject to increase periodically to include any accrued and unpaid  dividends) divided by the conversion price.  Upon the earlier of: (x) consummation of the Issuer’s sale (or series of related sales) of its capital stock (or securities convertible into its capital stock) from which the Issuer generates net proceeds of at least $25 million or (y) August 17, 2015 the Series B Convertible Preferred Shares shall automatically convert into the number of shares of Common Stock equal to the then current stated value divided by the conversion price.  If at any time the closing price of the shares of Common Stock is at least $1.59 for fifteen (15) consecutive trading days, the Issuer may redeem the outstanding Series B Convertible Preferred Shares at the then current stated value. The Series B Preferred Shares are redeemable each time in whole or in part for a period of 120-days thereafter.
 
16 The Series B Convertible Preferred Shares are convertible, at the option of the holder, into shares of Common Stock at the above conversion price if at any time the closing price of the shares of Common Stock is at least the conversion price for ten (10) consecutive trading days. Each time, for a period of 60-days thereafter, the Series B Convertible Preferred Shares are convertible into the number of shares of Common Stock equal to the then current stated value (initially $1,000, subject to increase periodically to include any accrued and unpaid  dividends) divided by the conversion price.  Upon the earlier of: (x) consummation of the Issuer’s sale (or series of related sales) of its capital stock (or securities convertible into its capital stock) from which the Issuer generates net proceeds of at least $25 million or (y) September 27, 2015 the Series B Convertible Preferred Shares shall automatically convert into the number of shares of Common Stock equal to the then current stated value divided by the conversion price.  If at any time the closing price of the shares of Common Stock is at least $1.75 for fifteen (15) consecutive trading days, the Issuer may redeem the outstanding Series B Convertible Preferred Shares at the then current stated value. The Series B Preferred Shares are redeemable each time in whole or in part for a period of 120-days thereafter.
 
17 The Series B Convertible Preferred Shares are convertible, at the option of the holder, into shares of Common Stock at the above conversion price if at any time the closing price of the shares of Common Stock is at least the conversion price for ten (10) consecutive trading days. Each time, for a period of 60-days thereafter, the Series B Convertible Preferred Shares are convertible into the number of shares of Common Stock equal to the then current stated value (initially $1,000, subject to increase periodically to include any accrued and unpaid  dividends) divided by the conversion price.  Upon the earlier of: (x) consummation of the Issuer’s sale (or series of related sales) of its capital stock (or securities convertible into its capital stock) from which the Issuer generates net proceeds of at least $25 million or (y) March 7, 2016 the Series B Convertible Preferred Shares shall automatically convert into the number of shares of Common Stock equal to the then current stated value divided by the conversion price.  If at any time the closing price of the shares of Common Stock is at least $3.85 for fifteen (15) consecutive trading days, the Issuer may redeem the outstanding Series B Convertible Preferred Shares at the then current stated value. The Series B Preferred Shares are redeemable each time in whole or in part for a period of 120-days thereafter.
 
 
 
12

 
CUSIP No. 17256R-105 SCHEDULE 13D Page 13 of 16 Pages
 
Kanavos beneficially owns (i) directly 23,377,473 shares of Common Stock (consisting of: (A) 354,254 shares of Common Stock owned of record by Kanavos; (B) 11,619,273 shares of Common Stock owned of record by Kanavos and his spouse, Dayssi Olarte de Kanavos, as joint tenants; (C) 500,000 shares of Common Stock owned of record by the Paul C. Kanavos 2008 GRAT; (D) 1,142,860 shares of Common Stock issuable upon the exercise of presently exercisable warrants held by Kanavos and his spouse, half of which are exercisable at $4.50 per share and the other half of which are exercisable at $5.50 per share;  (E) 100,000 shares of Common Stock issuable upon the exercise of stock options held by Kanavos that are presently exercisable at $5.00 per share; (F) 100,000 shares of Common Stock issuable upon the exercise of stock options held by Kanavos that are presently exercisable at $6.00 per share; (G) 390,626 shares of Common Stock issuable upon the exercise of warrants held by Kanavos and his spouse that are presently exercisable at $0.08 per share; (H) 151,099 shares of Common Stock issuable upon the conversion of the Issuer’s Series A Convertible Preferred Shares held by Kanavos and his spouse, as joint tenants, that are convertible at $0.2184 per share18; (I) 2,777,778 shares of Common Stock issuable upon the exercise of warrants held by Kanavos and his spouse, half of which are presently exercisable at $0.10 per share and the other half of which are presently exercisable at $0.11 per share; (J) 257,732 shares of Common Stock issuable upon the conversion of the Issuer’s Series A Convertible Preferred Shares held by Kanavos and his spouse, as joint tenants, that are convertible at $0.2328 per share19; (K) 856,531 shares of Common Stock issuable upon the conversion of the Issuer’s Series A Convertible Preferred Shares held by Kanavos and his spouse, as joint tenants, that are convertible at $0.2335 per share20; (L) 369,913 shares of Common Stock issuable upon the conversion of the Issuer’s Series A Convertible Preferred Shares held by Kanavos and his spouse, as joint tenants, that are convertible at $0.2433 per share21; (M) 238,435 shares of Common Stock issuable upon the conversion of the Issuer’s Series A Convertible Preferred Shares held by Kanavos and his spouse, as joint tenants, that are convertible at $0.2097 per share22; (N) 572,410 shares of Common Stock issuable upon the exercise of warrants held by Kanavos and his spouse that are presently exercisable at $0.2621 per share; (O) 171,606 shares of Common Stock issuable upon the conversion of the Issuer’s Series A Convertible Preferred Shares held by Kanavos and his spouse, as joint tenants, that are convertible at $0.1923 per share23; (P) 411,984 shares of Common Stock issuable upon the exercise of warrants held by Kanavos and his spouse that are presently exercisable at $0.2403 per share; (Q) 210,630 shares of Common Stock issuable upon the conversion of the Issuer’s Series A Convertible Preferred Shares held by Kanavos and his spouse that are convertible at $0.1614 per share24;  (R) 505,575 shares of Common Stock issuable upon the exercise of warrants held by Kanavos and his spouse that are presently exercisable at $0.2018 per share; (S) 260,552 shares of Common Stock issuable upon the conversion of the Issuer’s Series B Convertible Preferred Shares held by Kanavos and his spouse that are convertible at $0.1919 per share25; (T) 625,390 shares of Common Stock issuable upon the exercise of warrants held by Kanavos and his spouse that are presently exercisable at $0.2399 per share; (U) 560,600 shares of Common Stock issuable upon the conversion of the Issuer’s Series B Convertible Preferred Shares held by Kanavos and his spouse that are convertible at $0.2107 per share26; (V) 1,138,952 shares of Common Stock issuable upon the exercise of warrants held by Kanavos and his spouse that are presently exercisable at $0.2634 per share; (W) 18,023 shares of Common Stock issuable upon the conversion of Series B Convertible Preferred Shares held by Kanavos and his spouse that are convertible at $0.4622 per share27; and (X) 43,250 shares of Common Stock issuable upon the exercise of warrants held by Kanavos and his spouse that are presently exercisable at $0.5778 per share; and (ii) indirectly 16,558,481 shares of Common stock (consisting of: (A) 5,556,870 shares of Common Stock held by KDT; (B) 362,637 shares of Common Stock issuable upon the exercise of warrants held by KDT that are presently exercisable at $0.273 per share; (C) 618,557 shares of Common Stock issuable upon the exercise of warrants held by KDT that are presently exercisable at $0.291 per share; (D) 2,055,498 shares of Common Stock issuable upon the exercise of warrants held by KDT that are presently exercisable at $0.2919 per share; (E) 888,011 shares of Common Stock issuable upon the exercise of warrants held by KDT that are presently exercisable at $0.3041 per share; (F) 436,345 shares of Common Stock issuable upon the exercise of warrants held by KDT that are presently exercisable at $0.2621 per share; and (G) 5,501,611 shares of Common Stock (consisting of the shares of Common Stock owned of record by Atlas), which shares of Common Stock represent in the aggregate approximately 49.0% of the 81,480,107 shares of Common Stock deemed outstanding for such purpose, calculated based upon the sum of (x) 65,076,161 shares of Common Stock outstanding as of the date of this Statement and (y) the 16,403,946 shares of Common Stock issuable upon exercise of the aforesaid stock options, Series A Convertible Preferred Shares, Series B Preferred Shares and warrants.  Kanavos’ beneficial ownership excludes 500,000 shares of Common Stock owned of record by his spouse’s GRAT, the Dayssi Olarte de Kanavos 2008 GRAT.
 

18 See Note 11.
 
19 See Note 12.
 
21 See Note 9.
 
22 See Note 13.
 
23 See Note 10.
 
24See Note 14.
 
25 See Note 15.
 
26 See Note 16.
 
27See Note 17.
 
 
13

 
CUSIP No. 17256R-105 SCHEDULE 13D Page 14 of 16 Pages
 
Torino beneficially owns (i) directly 176,238 shares of Common Stock (consisting of 176,238 shares of Common Stock owned of record by Torino) and (ii) indirectly 38,235,221 shares of Common Stock (consisting of:  (A) 7,240,419 shares of Common Stock owned of record by TTERB; (B) 2,142,858 shares of Common Stock issuable upon the exercise of presently exercisable warrants held by TTERB, half of which are exercisable at $4.50 per share and the other half of which are exercisable at $5.50 per share; (C) 390,626 shares of Common Stock issuable upon the exercise of warrants held by TTERB that are presently exercisable at $0.08 per share; (D) 2,777,778 shares of Common Stock issuable upon the exercise of warrants held by TTERB, half of which are presently exercisable at $0.10 per share and the other half of which are presently exercisable at $0.11 per share; (E) 151,099 shares of Common Stock issuable upon the conversion of the Issuer’s Series A Convertible Preferred Shares held by TTERB that are convertible at $0.2184 per share28; (F) 362,637 shares of Common Stock issuable upon the exercise of warrants held by TTERB that are presently exercisable at $0.273 per share; (G) 257,732 shares of Common Stock issuable upon the conversion of the Issuer’s Series A Convertible Preferred Shares held by TTERB that are convertible at $0.2328 per share29; (H) 618,557 shares of Common Stock issuable upon the exercise of warrants held by TTERB that are presently exercisable at $0.291 per share; (I) 856,531 shares of Common Stock issuable upon the conversion of the Issuer’s Series A Convertible Preferred Shares held by TTERB that are convertible at $0.2335 per share30; (J) 2,055,498 shares of Common Stock issuable upon the exercise of warrants held by TTERB that are presently exercisable at $0.2919 per share; (K) 369,913 shares of Common Stock issuable upon the conversion of the Issuer’s Series A Convertible Preferred Shares held by TTERB that are convertible at $0.2433 per share31; (L) 888,011 shares of Common Stock issuable upon the exercise of warrants held by TTERB that are presently exercisable at $0.3041 per share; (M) 238,435 shares of Common Stock issuable upon the conversion of the Issuer’s Series A Convertible Preferred Shares held by TTERB that are convertible at $0.2097 per share32; (N) 572,410 shares of Common Stock issuable upon the exercise of warrants held by TTERB that are presently exercisable at $0.2621 per share; (O) 171,606 shares of Common Stock issuable upon the conversion of the Issuer’s Series A Convertible Preferred Shares held by TTERB that are convertible at $0.1923 per share33; (P) 411,984 shares of Common Stock issuable upon the exercise of warrants held by TTERB that are presently exercisable at $0.2403 per share; (Q) 210,630 shares of Common Stock issuable upon the conversion of the Issuer’s Series A Convertible Preferred Shares held by TTERB that are convertible at $0.1614 per share34; (R) 505,575 shares of Common Stock issuable upon the exercise of warrants held by TTERB that are presently exercisable at $0.2018 per share; (S) 260,552 shares of Common Stock issuable upon the conversion of the Issuer’s Series B Convertible Preferred Shares held by TTERB that are convertible at $0.1919 per share35; (T) 625,390 shares of Common Stock issuable upon the exercise of warrants held by TTERB that are presently exercisable at $0.2399 per share; (U) 560,600 shares of Common Stock issuable upon the conversion of the Issuer’s Series B Convertible Preferred Shares held by TTERB that are convertible at $0.2107 per share36; (V) 1,138,952 shares of Common Stock issuable upon the exercise of warrants held by TTERB that are presently exercisable at $0.2634 per share; (W) 43,250 shares of Common Stock issuable upon the exercise of warrants held by TTERB that are presently exercisable at $0.5778 per share; (X) 18,023 shares of Common Stock issuable upon the conversion of Series B Convertible Preferred Shares held by TTERB that are convertible at $0.4622 per share37; (Y) 7,781,210 shares of Common Stock held by TS; (Z) 1,041,667 shares of Common Stock issuable upon the exercise of warrants held by TS that are presently exercisable at $0.07 per share; (AA) 1,041,667 shares of Common Stock issuable upon the exercise of warrants held by TS that are presently exercisable at $0.08 per share; and (BB) 5,501,611 shares of Common Stock owned of record by Atlas), which shares of Common Stock represent in the aggregate approximately 46.4% of the 82,788,142 shares of Common Stock deemed outstanding for such purpose, calculated based upon the sum of (x) 65,076,161 shares of Common Stock outstanding as of the date of this Statement and (y) the 17,711,981 shares of Common Stock issuable upon exercise of the aforesaid Series A Convertible Preferred Shares, Series B Preferred Shares and warrants.
 

28 See Note 11.
 
29 See Note 12.
 
30 See Note 8.
 
31 See Note 9.
 
32 See Note 13.
 
33 See Note 10.
 
34 See Note 14.
 
35See Note 15.
 
 See Note 16.
 
37 See Note 17.
 
 
14

 
 
CUSIP No. 17256R-105 SCHEDULE 13D Page 15 of 16 Pages
 
Atlas beneficially owns 5,501,611 shares of Common Stock, which represents approximately 8.5% of the 65,076,161 shares of Common Stock outstanding as of the date of this Statement.  Sillerman, Kanavos and Torino (through TTERB), by virtue of owning a combined approximately 76% voting interest in Atlas and serving as its directors and executive officers, also are deemed to have beneficial ownership of these shares of Common Stock.
 
(b) As of the date of this Statement:
 
Of the Common Stock reported herein as being beneficially owned by Sillerman, Sillerman possesses sole voting power and sole dispositive power over 9,350,263 shares of Common Stock and possesses shared voting power and dispositive power over 23,910,664 shares of Common Stock.
 
Of the Common Stock reported herein as being beneficially owned by Kanavos, Kanavos possesses sole voting and sole dispositive power over 1,034,254 shares of Common Stock and possesses shared voting power and dispositive power over 38,901,700 shares of Common Stock.
 
Of the Common Stock reported herein as being beneficially owned by KDT, KDT possesses shared voting power and dispositive power over 11,056,870 shares of Common Stock.
 
Of the Common Stock reported herein as being beneficially owned by Torino, Torino possesses sole voting and sole dispositive power over 176,238 shares of Common Stock and possesses shared voting power and dispositive power over 38,235,221shares of Common Stock.
 
Of the Common Stock reported herein as being beneficially owned by TTERB, TTERB  possesses shared voting power and dispositive power over 28,370,677 shares of Common Stock.
 
Of the Common Stock reported herein as being beneficially owned by TS, TS possesses shared voting power and dispositive power over 9,864,544 shares of Common Stock.
 
Of the Common Stock reported herein as being beneficially owned by Atlas, Atlas possesses shared voting power and dispositive power over all of the 5,501,611 shares of Common Stock.
 
(c) Except for the private transaction described in Item 3 above, the Reporting Persons have not effected any transactions in the Common Stock during the past sixty days.
 
Item 6.
Contracts, Arrangements, Understandings or Relationships With Respect to Securities of the Issuer.
 
Item 6 of the Statement is hereby amended to add the following information:
 
As reported in Item 3 above, on September 30, 2013, TS and the Huff Funds entered into the Purchase Agreement pursuant to which TS purchased, among other securities, an aggregate of 1,041,667 common stock purchase warrants to purchase up to 1,041,667 shares of Common Stock at an exercise price of $0.07 per share and an aggregate of 1,041,667 common stock purchase warrants to purchase up to 1,041,667 shares of Common Stock at an exercise price of $0.08 per share.  These common stock purchase warrants expire on September 4, 2016, are immediately exercisable, are subject to anti-dilution protection for stock splits and similar events and are identical in all respects except for their exercise prices. The foregoing description of these common stock purchase warrants is qualified in its entirety by reference to the text of the common stock purchase warrants, the form of which was previously filed herewith as Exhibit 15 and is incorporated herein by reference.  The Purchase Agreement is filed herewith as Exhibit 25 and is incorporated herein by reference.
 
On October 2, 2013, the Reporting Persons entered into a Fourth Amended and Restated Joint Filing Agreement. A copy of the Fourth Amended and Restated Joint Filing Agreement is filed herewith as Exhibit 26 and is incorporated herein by reference.
Item 7.
Material to be filed as Exhibits.
 
Item 7 of the Statement is hereby amended to add the following exhibit:
 
Exhibit Number   Description
     
25  
Securities Purchase and Sale Agreement dated as of September 30, 2013 by and between TS 2013 LLC and The Huff Alternative Fund, L.P. and The Huff Alternative Parallel Fund, L.P.
     
26  
Fourth Amended and Restated Joint Filing Agreement dated October 2, 2013 by and among Robert F.X. Sillerman, Paul C. Kanavos, Kanavos Dynasty Trust 2011, Brett Torino, TTERB Living Trust, TS 2013 LLC and Atlas Real Estate Funds, Inc.
 
 
 
 
15

 
 
SIGNATURES
 
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
 
 
       
Dated: October 2, 2013
  /s/ Robert F.X. Sillerman  
   
Robert F.X. Sillerman
 
       
Dated: October 2, 2013
  /s/ Paul C. Kanavos  
   
Paul C. Kanavos
 
       
Dated: October 2,, 2013
 
Kanavos Dynasty Trust 2011
 
       
   
Deutsche Bank Trust Company Delaware, as Trustee
 
       
  By:
/s/ Donna G. Mitchell
 
   
Name: Donna G. Mitchell
 
   
Title: Vice President
 
       
    /s/ Edward A. Reznick  
   
Name: Edward A. Reznick
 
    Title: President  
       
Dated: October 2, 2013
  /s/ Brett Torino  
   
Brett Torino
 
       
Dated: October 2, 2013
 
TTERB Living Trust
 
       
    /s/ Brett Torino  
  By:
Brett Torino, as Trustee
 
       
Dated: October 2, 2013
 
TS 2013 LLC
 
       
  By: Onirot Living Trust dated  
    6/20/2000 (Member)  
       
    /s/ Brett Torino  
  By:
Brett Torino, as Trustee
 
       
Dated: October 2, 2013
 
Atlas Real Estate Funds, Inc.
 
       
  By:
/s/ Paul Kanavos
 
    Name: Paul Kanavos  
   
Title: President
 
 
16

 
EX-25 2 cexe_ex25.htm cexe_ex25.htm
Exhibit 25
 

SECURITIES PURCHASE AND SALE AGREEMENT
 
Dated as of September 30, 2013

This Securities Purchase and Sale Agreement (this “Agreement”) is by and between TS 2013 LLC, a Nevada limited liability company (the “Purchaser”), on the one hand, and The Huff Alternative Fund, L.P., a Delaware limited partnership (the “Huff Alternative Fund”), and The Huff Alternative Parallel Fund, L.P., a Delaware limited partnership (the “Huff Alternative Parallel Fund” and, together with the Huff Alternative Fund, collectively the “Huff Funds”), on the other hand.
 
WHEREAS, the Huff Funds own securities of Circle Entertainment Inc., a Delaware corporation formerly known as FX Real Estate and Entertainment Inc. (“Circle Entertainment”); and all of such securities are described in detail on Schedule A attached to this Agreement.
 
WHEREAS, shares of Circle Entertainment’s common stock, par value $0.01 per share (“Circle Common Stock”), are publicly registered with the U.S. Securities and Exchange Commission and are quoted on the OTC Markets under the trading symbol “CEXE.”
 
WHEREAS, the Huff Funds and the Torino Parties have agreed that the Purchaser will purchase all of the Circle Entertainment securities held by the Huff Funds, on the terms and conditions set forth in this Agreement.
 
NOW, THEREFORE, in consideration of the mutual agreements, covenants, representations, warranties and indemnities contained in this Agreement, and for other good and valuable consideration, the receipt of which is hereby acknowledged by each of the parties hereto, the Purchaser and the Huff Funds, intending to be legally bound, hereby agree as follows:
 
1. Purchase and Sale of Securities.
 
(a) On the terms and subject to the conditions set forth in this Agreement, at the closing described in Section 2 hereof (the “Closing”), the Purchaser shall purchase, acquire and accept from the Huff Funds, and the Huff Funds shall sell, transfer, assign and deliver to the Purchaser:
 
(i) the 7,781,209 shares (the “Common Shares”) of Circle Common Stock described on lines 1 and 2 of Schedule A attached hereto; and
 
(ii) (A) the warrants to purchase 1,041,667 shares of Circle Common Stock at an exercise price of $0.07 per share (the “$0.07 Warrants”) owned as described on lines 3 and 4 of Schedule A attached hereto, (B) the warrants to purchase 1,041,667 shares of Circle Common Stock at an exercise price of $0.08 per share (the “$0.08 Warrants”) owned as described on lines 5 and 6 of Schedule A attached hereto; and (C) the one (1) share of Circle Entertainment’s “Non-Voting Designated Preferred Stock,” par value $0.01 per share (the “Special Preferred Share”), described on line 7 of Schedule A attached hereto;
 
in each case free and clear of all liens, claims, security interests, options, restrictions and other encumbrances (collectively, “Liens”), except, in the case of the Special Preferred Share, for restrictions that arise under the express provisions of the Certificate of Designation filed by Circle Entertainment in 2008 with respect to the Circle Entertainment “Non-Voting Designated Preferred Stock.”  Anything to the contrary notwithstanding, the Purchaser may delegate its right to purchase the Common Shares, the $0.07 Warrants, the $0.08 Warrants and the Special Preferred Share (collectively, the “Subject Securities”) to any other person or entity, provided that no such delegation shall relieve the Purchaser of any of its obligations hereunder.
 
(b) As full consideration for the Subject Securities, at the Closing the Purchaser shall pay to the Huff Funds:
 
(i) for the Common Shares, a purchase price of $0.025 per share, or an aggregate purchase price of $194,530.23 in cash (the “Common Shares Purchase Price”); and
 
(ii) for the $0.07 Warrants, the $0.08 Warrants and the Special Preferred Share, a purchase price of $0.00263 per share (or, as applicable, per share purchase right), or an aggregate purchase price of $5,479.16, in cash (the “Warrants and Preferred Securities Purchase Price” and, together with the Common Shares Purchase Price, the “Aggregate Price”).
 
 
1

 
2. Closing.  The consummation of the transactions contemplated hereby (the “Closing”) shall take place at the offices of Troutman Sanders LLP, 405 Lexington Avenue, New York, New York 10174, at 10:00 a.m. on a date (the “Closing Date”) within thirty (30) days after the date of this Agreement, provided that all of the conditions contained in Section 5 hereof shall have been either satisfied or waived by the appropriate party prior to the Closing, or on such other date and at such other place and time as may be mutually agreed to by the parties hereto in writing.
 
3. Closing Deliveries.
 
3.1 Closing Deliveries by the Huff Funds.  At the Closing, the Huff Funds shall deliver or cause to be delivered to the Purchaser:
 
(i) Stock transfer powers with respect to all of the Common Shares, duly executed in blank by the applicable Huff Fund;
 
(ii) The original certificate representing the $0.07 Warrants, together with warrant transfer powers with respect to the $0.07 Warrants duly executed in blank by the applicable Huff Fund;
 
(iii) The original certificate representing the $0.08 Warrants, together with warrant transfer powers with respect to the $0.08 Warrants duly executed in blank by the applicable Huff Fund;
 
(iv) The original stock certificate representing the Special Preferred Share, together with a stock transfer power with respect to the Special Preferred Share duly executed in blank by the applicable Huff Fund; and
 
(v) the resignation of Bryan Bloom  as a director of Circle Entertainment, effective immediately upon delivery.
 
3.2 Closing Deliveries by the Purchaser.  At the Closing, the Purchaser shall deliver or cause to be delivered to the Huff Funds:
 
(i) The Aggregate Price (which equals $200,009.39) by two wire transfers of immediately available funds to the separate bank accounts of the Huff Funds as specified on Exhibit A attached hereto.
 
4. Representations and Warranties.
 
4.1 Representations and Warranties of the Purchaser.  The Purchaser hereby represents and warrants to the Huff Funds as follows:
 
(a) The Purchaser is duly organized, validly existing and in good standing under the laws of the jurisdiction of its organization.
 
(b) The execution, delivery and performance of this Agreement by the Purchaser are within the powers of the Purchaser, have been duly authorized by all necessary action by and on behalf of the Purchaser, require no action with respect to the Purchaser by or in respect of, or filing with respect to the Purchaser with, any governmental body, agency or official (other than actions fully performed and filings duly made prior to the date of this Agreement), and do not contravene or constitute a default under any of the organizational documents of the Purchaser, or under any provision of applicable law or any agreement, judgment, injunction, order, decree or other instrument to which the Purchaser is a party or that is binding upon it.
 
(c) This Agreement has been duly authorized, executed and delivered by the Purchaser and constitutes the legal, valid and binding agreement of the Purchaser, enforceable against the Purchaser in accordance with its terms.
 
(d) The Purchaser is acquiring the Subject Securities for its own account, for investment and not with a view to the distribution or resale thereof, except in compliance with the Securities Act of 1933, as amended (the “Securities Act”), and applicable state securities laws.
 
(e) To the knowledge of the Purchaser, no statute, law, rule, regulation, judgment or order of any nature issued by a court or other governmental authority restrains, limits, prohibits or affects the transactions contemplated by this Agreement, and no claim, suit, action, investigation, inquiry or other proceeding by any court or other governmental authority or other person or entity is pending, or threatened, that questions the validity or legality of the transactions contemplated by this Agreement.
 
(f) The Purchaser has such knowledge and experience in financial and business matters and in making investments similar to the Subject Securities that it is capable of evaluating the merits and risks of purchasing the Subject Securities.
 
 
2

 
(g) The Purchaser is an “accredited investor,” as that term is defined in Rule 501(a) of Regulation D under the Securities Act.
 
(h) The Purchaser acknowledges that (i) the Huff Funds and their affiliates may be in possession of material non-public information about Circle Entertainment which information is not possessed by the Purchaser; (ii) the Huff Funds have not disclosed, and prior to the Closing will not disclose, any non-public information about Circle Entertainment to the Purchaser, and the Purchaser has not requested that any such information be disclosed to it; (iii) the Purchaser may be at a disadvantage due to a disparity of information regarding Circle Entertainment as between the Huff Funds, on the one hand, and the Purchaser, on the other hand; (iv) the Purchaser has made an independent decision to purchase the Subject Securities from the Huff Funds based on the information available to the Purchaser, which the Purchaser has determined is adequate for that purpose.
 
(i) The Purchaser acknowledges that the Huff Funds are relying on the representations and warranties set forth in this Section 4.1 in agreeing to sell the Subject Securities and in agreeing to the other matters set forth in this Agreement; and the Huff Funds would not enter into this Agreement in the absence of such representations and warranties.
 
4.2 Representations and Warranties of the Huff Funds.  Each of the Huff Funds, severally but not jointly, hereby represents and warrants to the Purchaser as follows:
 
(a) Such Huff Fund is duly organized, validly existing and in good standing under the laws of the jurisdiction of its organization.
 
(b) The execution, delivery and performance of this Agreement by such Huff Fund are within the powers of such Huff Fund, have been duly authorized by all necessary action by and on behalf of such Huff Fund, require no action with respect to such Huff Fund by or in respect of, or filing with respect to such Huff Fund with, any governmental body, agency or official (other than actions fully performed and filings duly made prior to the date of this Agreement), and do not contravene or constitute a default under any of the organizational documents of such Huff Fund, or under any provision of applicable law or any agreement, judgment, injunction, order, decree or other instrument to which such Huff Fund is a party or that is binding upon it.
 
(c) This Agreement has been duly authorized, executed and delivered by such Huff Fund and constitutes the legal, valid and binding agreement of such Huff Fund, enforceable against such Huff Fund in accordance with its terms.
 
(d) Such Huff Fund has such knowledge and experience in financial and business matters and in disposing of investments similar to the Subject Securities that it is capable of evaluating the merits and risks of selling the Subject Securities.
 
(e) Such Huff Fund is an “accredited investor,” as that term is defined in Rule 501(a) of Regulation D under the Securities Act.
 
(f) To the knowledge of such Huff Fund, no statute, law, rule, regulation, judgment or order of any nature issued by a court or other governmental authority restrains, limits, prohibits or affects the transactions contemplated by this Agreement, and no claim, suit, action, investigation, inquiry or other proceeding by any court or other governmental authority or other person or entity is pending, or threatened, that questions the validity or legality of the transactions contemplated by this Agreement.
 
(g) The Subject Securities indentified on Schedule A attached hereto as being owned by such Huff Fund constitute all securities, rights and interests of any kind in Circle Entertainment owned or controlled by such Huff Fund and at the Closing the Purchaser will obtain good, valid and marketable title to such Subject Securities free and clear of any and all Liens.
 
(h) Such Huff Fund acknowledges that (i) the Purchaser and its affiliates may be in possession of material non-public information about Circle Entertainment which information is not possessed by such Huff Fund; (ii) the Purchaser has not disclosed, and prior to the Closing will not disclose, any non-public information about Circle Entertainment to such Huff Fund, and such Huff Fund has not requested that any such information be disclosed to it; (iii) such Huff Fund may be at a disadvantage due to a disparity of information regarding Circle Entertainment as between the Purchaser, on the one hand, and such Huff Fund, on the other hand; (iv) such Huff Fund has made an independent decision to sell the applicable Subject Securities to the Purchaser based on the information available to such Huff Fund, which such Huff Fund has determined is adequate for that purpose.
 
(i) Such Huff Fund acknowledges that the Purchaser is relying on the representations and warranties set forth in this Section 4.2 in agreeing to purchase the Subject Securities and in agreeing to the other matters set forth in this Agreement; and the Purchaser would not enter into this Agreement in the absence of such representations and warranties.
 
 
3

 
5. Closing Conditions.
 
5.1 Conditions to Obligations of the Purchaser at the Closing.  The obligation of the Purchaser to consummate the Closing is subject to the satisfaction of the following conditions, any of which may be waived by the Purchaser in writing:
 
(i) Each of the representations and warranties of the Huff Funds made in this Agreement shall be true and correct in all material respects as of the date of this Agreement and as of the Closing (as if made at and as of the Closing).
 
(ii) No provision of any applicable law and no order or proceeding shall be in effect or pending that does or purports to prohibit or restrict any provision of this Agreement or any of the transactions contemplated hereby including the consummation of the Closing.
 
(iii) All actions by or in respect of, or filings by, the Huff Funds with any person, entity or governmental authority required to permit the consummation of the Closing by the Huff Funds shall have been taken or made.
 
5.2 Conditions to Obligations of the Huff Funds at the Closing.  The obligations of the Huff Funds to consummate the Closing are subject to the satisfaction of the following conditions, any of which may be waived by the Huff Funds in writing:
 
(i) Each of the representations and warranties of the Purchaser made in this Agreement shall be true and correct in all material respects as of the date of this Agreement and as of the Closing (as if made at and as of the Closing).
 
(ii) No provision of any applicable law and no order or proceeding shall be in effect that does or purports to prohibit or restrict any provision of this Agreement or the transactions contemplated hereby including the consummation of the Closing.
 
(iii) All actions by or in respect of, or filings by, the Purchaser with any person, entity or governmental authority required to permit the consummation of the Closing by the Purchaser shall have been taken or made.
 
6. Other Covenants; Certain Interpretive Matters.
 
6.1 Confidentiality.  Each of the parties hereto shall keep all of the terms and provisions of this Agreement completely confidential, and shall not disclose any such information to anyone other than such party’s professional representatives (i.e., attorneys, accountants and financial advisors) who have been informed of and have agreed to abide by this confidentiality obligation; provided, however, that a party may make such disclosures as it reasonably believes, upon advice of counsel, it is required to disclose by law, rule or regulation.
 
6.2 Further Actions and Assurances.  From time to time after the execution and delivery of this Agreement and the Closing, each of the parties hereto shall take all such further actions, and execute and deliver all such further documents and instruments, as the other party may reasonably request in order to give full effect to the matters contemplated in this Agreement.  Without limiting the foregoing, the Purchaser and the Huff Funds shall notify Circle Entertainment of the sale and purchase of the Subject Securities promptly after the Closing, and shall provide Circle Entertainment and its transfer agent with all necessary and appropriate documentation to register the Subject Securities (as applicable) in the name of the Purchaser or its designee or designees.
 
6.3 Specific Performance.  Each of the parties hereto would be damaged irreparably in the event any of the provisions of this Agreement is not performed in accordance with its specific terms or is otherwise breached in any respect.  Therefore, in addition to any other remedy to which a party hereto may be entitled pursuant the terms hereof or under applicable law, each party shall be entitled to an injunction or injunctions to prevent or remedy a breach of this Agreement by any other party or to enforce specifically this Agreement and the terms and provisions hereof, in each case without any requirement to post a bond or to demonstrate actual or irreparable harm.
 
6.4 Survival of Representations and Warranties.  The representations and warranties of the parties contained in this Agreement shall survive the execution and delivery of this Agreement and the Closing hereunder.
 
6.5 Headings.  The subject headings of the sections and subsections of this Agreement are included for convenience only and shall not affect construction or interpretation of any of its provisions.
 
6.6 Joint Drafting.  This Agreement has been jointly drafted by the parties hereto, after negotiations and consultations with their respective counsel.  This Agreement shall not be construed more strictly against one or more parties than against any other party.
 
 
4

 
7. Purchaser Indemnification of Huff Funds.
 
(a) Pursuant to the provisions of this Section 7, the Purchaser will defend, indemnify and hold harmless each of the Huff Funds, and its respective equityholders, directors, officers, successors or assigns (collectively, the “Huff Indemnitees”), from and against all losses, liabilities, demands, claims, or causes of action, regulatory, legislative or judicial proceedings or investigations, assessments, levies, fines, penalties, damages, costs and expenses (including reasonable attorneys’, accountants’ investigators’ and experts’ fees and expenses) (“Damages”) sustained or incurred by such person arising from or related to: (i)  any claim or proceeding brought by any party (other than an affiliate of, or investor in, either of the Huff Funds) alleging that this Agreement is unlawful, in any way inequitable or provides the Purchaser inadequate consideration for any consideration given or deemed given in connection with the transactions in connection with this Agreement; or (ii)  any breach by the Purchaser of any of its representations and warranties set in this Agreement.  All claims for indemnification hereunder shall be asserted and resolved pursuant to the procedures set forth in Section 7(b), Section 7(c), Section 7(d), Section 7(e) and Section 7(f) hereof.
 
(b) In the event that any written claim or demand for which the Purchaser would be liable is asserted against or sought to be collected from any Huff Indemnitee by a third party, the applicable Huff Indemnitee shall promptly, but in no event more than 30 days following the Huff Indemnitee’s receipt of such claim or demand, notify the Purchaser of such claim or demand and furnish all information regarding such claim or demand reasonably available to the Huff Indemnitee (the “Claim Notice”).  The failure of a Huff Indemnitee to provide timely notice of the existence of a third party claim or demand to the Purchaser shall not diminish or impair the obligation of the Purchaser to indemnify under this Section 7 except to the extent such failure damages the Purchaser or prejudices the ability of the Purchaser to defend the claim or demand.  The Purchaser shall have 21 days from the delivery or receipt of the Claim Notice (the “Notice Period”) to notify the Huff Indemnitee (a) whether or not the Purchaser disputes the obligation of the Purchaser to indemnify the Huff Indemnitee hereunder with respect to such claim or demand and (b) whether or not the Purchaser desires to defend the Huff Indemnitee against such claim or demand.  All costs and expenses incurred by the Purchaser in defending such claim or demand shall be a liability of, and shall be paid by, the Purchaser.
 
(c) In the event that the Purchaser notifies the applicable Huff Indemnitee within the Notice Period that it desires to defend the Huff Indemnitee against such claim or demand and except as hereinafter provided, the Purchaser shall have the right to defend the Huff Indemnitee, provided that the Purchaser shall conduct the defense of such claim or demand with reasonable diligence.
 
(d) All costs and expenses incurred by the Purchaser in defending such claim or demand, and all reasonable costs and expenses incurred by the applicable Huff Indemnitee in defending such claim or demand if the Purchaser fails to notify the Huff Indemnitee of the Purchaser’s election to defend the claim or demand within the Notice Period, shall be a liability of, and shall be paid by, the Purchaser.
 
(e) Each of the Huff Indemnitees and the Purchaser shall cooperate with each other and render to each other such assistance as may reasonably be requested in order to ensure the proper and adequate defense of any such claim or demand.  The party in charge of the defense shall keep the other party reasonably apprised at all times as to the status of the defense or any settlement negotiations with respect thereto.  Except as otherwise provided herein, if any Huff Indemnitee desires to participate in, but not control, any such defense or settlement it may do so at its sole cost and expense.
 
(f) In the event that the Purchaser does not defend the claim (whether because of a failure to deliver a timely notice as provided above, or a failure to conduct the defense or settlement with reasonable diligence or otherwise), the applicable Huff Indemnitee may settle, compromise or defend a claim or demand at the sole expense of the Purchaser.  The Purchaser shall not, without the prior written consent of the Huff Indemnitee, settle, compromise or offer to settle or compromise any such claim or demand unless such settlement or compromise (i) unconditionally releases the Huff Indemnitee from all liabilities and obligations with respect to such claim or demand and (ii) results in the dismissal with prejudice of any litigation or other proceeding with respect to such claim or demand, in each case for the benefit of the Huff Indemnitee.
 
8. Miscellaneous.
 
(a) Entire Agreement; Modifications; Waivers.  This Agreement constitutes the entire Agreement between the parties pertaining to the subject matter hereof and supersedes all prior and contemporaneous agreements, representations and understandings of the parties with respect to such subject matter.  This Agreement may be amended or modified, and any of the terms, covenants, representations, warranties or conditions hereof may be waived, only by a written instrument executed by the parties hereto, or in the case of a waiver, by the party waiving compliance.  Neither any waiver by any party of any condition, nor any breach of any provision, term, covenant, representation or warranty, contained in this Agreement, in any one or more instances, shall be deemed to be or construed as a further or continuing waiver of any such condition, or of the breach of any other provision, term, covenant, representation or warranty of this Agreement.
 
 
5

 
(b) Notices.  All notices, requests, demands and other communications under this Agreement shall be in writing (including email or similar writing) and shall be effective:  (i) on the date of delivery if delivered personally on  party to whom notice is to be given; (ii) on the date of delivery if provided by email if property received at designated email address; (iii) on  the fifth (5th) day after mailing if mailed to  party to whom notice is to be given, by overnight courier delivery and addressed as detailed below; or (iv) if given by any other means, when actually delivered at such address:
 
If to the Purchaser:
 
TS 2013 LLC
70 East 55th Street
New York, New York 10022
E-Mail: mnelson@circlexe.com
Facsimile:
Attention:  Mitchell J. Nelson, Esq.

With copies to:

Troutman Sanders LLP
The Chrysler Building
405 Lexington Avenue
New York, New York 10174
E-Mail:  timothy.kahler@troutmansanders.com
Facsimile:  (212) 704-5948
Attn:    Timothy I. Kahler, Esq.
 
If to The Huff Funds:
 
The Huff Alternative Fund, L.P.
The Huff Alternative Parallel Fund, L.P.
67 Park Place
Morristown, New Jersey 07960
E-Mail: beb@huffcompanies.com
Facsimile: (973) 984-5818
Attention: Bryan Bloom, Esq.

With copies to:
 
Dennis J. Drebsky
Nixon Peabody LLP
437 Madison Avenue
New York, New York 10022
E-Mail: ddrebsky@nixonpeabody.com
Facsimile: 866-678-8786

 
6

 
Any party may change its address for purposes of this section by giving the other parties written notice of a new address in a manner set forth above.

(c) Severability.  If any provision of this Agreement is, for any reason, invalid or unenforceable, the remaining provisions of this Agreement shall nevertheless be valid and enforceable and will remain in full force and effect.  Any provision of this Agreement that is held invalid or unenforceable by a court of competent jurisdiction will be deemed modified to  extent necessary to make it valid and enforceable and is so modified will remain in full force and effect.
 
(d) Successors and Assigns.  This Agreement is binding on and shall inure to the benefit of each party hereto and its respective successors and permitted assigns.  This Agreement may not be transferred or assigned without the express written consent of the other parties hereto, which consent may be denied in the sole discretion of such other parties for any reason or no reason whatsoever.
 
 
(e) Governing Law; Jurisdiction; Jury Trial Waiver, Etc.  This Agreement shall be construed, performed and enforced in accordance with, and governed by, the Law of the State of New York, other than any provisions thereof that would result in the application of the Law of any other jurisdiction.  Every action or proceeding of any kind seeking to enforce any provision of, or based on any right arising out of, this Agreement shall be brought against any of the parties in a New York Court (as hereinafter defined), and each of the parties consents to the sole and exclusive jurisdiction of such courts in any such action or proceeding and waives any objection to venue laid therein.  Process in any action or proceeding referred to in the preceding sentence may be served on any party in accordance with the procedures for notices provided in Section 8(b) hereof.  Each of the parties irrevocably waives any objection, including any objection to the laying of venue or based on the grounds of forum non conveniens, that it may now or hereafter have to the bringing of any action or proceeding in such jurisdiction in respect of this Agreement or the transactions contemplated hereby.  “New York Court” means the courts of the state of New York that preside in the county of New York (i.e., in the Borough of Manhattan), or, if it has or can acquire jurisdiction, in the United States District Court for the Southern District of New York, and in each case the respective appellate courts as necessary or applicable.  Each party hereby irrevocably waives its rights to a jury trial of any claim or cause of action arising out of or relating to this Agreement or the Release.
 
(f) Counterparts.  This Agreement may be executed in one or more counterparts, each of which will be deemed an original, but all of which, taken together, will constitute one and the same instrument.  Photocopies and facsimile signatures will be treated in all respects as original signatures for all purposes herein.
 
(g) Expenses.  Each of the parties hereto shall pay or cause to be paid the fees and expenses incurred by it and its affiliates in connection with the preparation, negotiation and execution of this Agreement and the consummation of the transactions contemplated hereby.
 

[The remainder of this page is intentionally blank.]

 
7

 

IN WITNESS WHEREOF, the undersigned have executed this Agreement as of the date first above written.
 
 
TS 2013 LLC
 
  By: Onirot Living Trust dated 6/20/2000  
    (Member)  
       
 
By:
/s/ Brett Torino  
    Brett Torino, Trustee  
       
 
THE HUFF ALTERNATIVE FUND, L.P.
 
  By: 
WRH Partners II, LLC,
its General Partner
 
       
  By: /s/ Bryan Bloom  
    Name:  Bryan Bloom  
    Title:    Counsel  
       
 
THE HUFF ALTERNATIVE PARALLEL FUND, L.P.
 
  By:
WRH Partners II, LLC,
its General Partner
 
       
  By: /s/ Bryan Bloom  
    Name:  Bryan Bloom  
    Title:    Counsel  

 
 
8

 

SCHEDULE A


Circle Entertainment Inc.
Securities Owned by the Huff Funds


 
Description of Security
 
Name of Owner
 
Number of Securities
1.
Common Stock, par value $0.01 per share
 
The Huff Alternative Fund, L.P.
 
6,594,624 shares
2.
Common Stock, par value $0.01 per share
 
The Huff Alternative Parallel Fund, L.P.
 
1,186,585 shares
3.
Warrants to purchase shares of Common Stock at an exercise price of $0.07 per share
 
The Huff Alternative Fund, L.P.
 
Warrant to purchase 1,019,269 shares
4.
Warrants to purchase shares of Common Stock at an exercise price of $0.07 per share
 
The Huff Alternative Parallel Fund, L.P.
 
Warrant to purchase 22,398 shares
5.
Warrants to purchase shares of Common Stock at an exercise price of $0.08 per share
 
The Huff Alternative Fund, L.P.
 
Warrant to purchase 1,019,269 shares
6.
Warrants to purchase shares of Common Stock at an exercise price of $0.08 per share
 
The Huff Alternative Parallel Fund, L.P.
 
Warrant to purchase 22,398 shares
7.
Non-Voting Designated Preferred Stock, par value $0.01 per share
 
The Huff Alternative Fund, L.P.
 
One (1) share




EX-26 3 cexe_ex26.htm cexe_ex26.htm
EXHIBIT 26
 
FOURTH AMENDED AND RESTATED JOINT FILING AGREEMENT PURSUANT TO RULE 13D-1(K)(1)
 
This Agreement is made pursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended (the "Act") by and among the parties listed below, each referred to herein as a "Joint Filer." The Joint Filers agree that a statement of beneficial ownership as required by Section 13(d) of the Act and the Rules thereunder may be filed on each of their behalf on Schedule 13D or Schedule 13G, as appropriate, and that said joint filing may thereafter be amended by further joint filings. The Joint Filers state that they each satisfy the requirements for making a joint filing under Rule 13d-1.
 
       
 
  /s/ Robert F.X. Sillerman  
   
Robert F.X. Sillerman
 
       
    /s/ Paul C. Kanavos  
   
Paul C. Kanavos
 
       
   
Kanavos Dynasty Trust 2011
 
       
   
Deutsche Bank Trust Company Delaware, as Trustee
 
       
  By:
/s/ Donna G. Mitchell
 
   
Name: Donna G. Mitchell
 
   
Title: Vice President
 
       
    /s/ Edward A. Reznick  
   
Name: Edward A. Reznick
 
    Title: President  
       
    /s/ Brett Torino  
   
Brett Torino
 
       
   
TTERB Living Trust
 
       
    /s/ Brett Torino  
  By:
Brett Torino, as Trustee
 
       
   
TS 2013 LLC
 
       
  By: Onirot Living Trust  
    dated 6/20/2000 (Member)  
       
    /s/ Brett Torino  
  By:
Brett Torino, as Trustee
 
       
   
Atlas Real Estate Funds, Inc.
 
       
  By:
/s/ Paul Kanavos
 
    Name: Paul Kanavos  
   
Title: President